Xinyuan Ding
Impact in
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Ubiquitin and proteasome pathways 3
- Histone Deacetylase Inhibitors Research 2
-
- Protease and Inhibitor Mechanisms 2
- Co-authors
- Wenjuan Wang (9 shared papers)Min Jin (7 shared papers)Yanyun Zhang (7 shared papers)Zheng Wang (3 shared papers)Mingxing Xue (4 shared papers)Caihong Tan (3 shared papers)Jiefang Huang (5 shared papers)Kunwei Shen (2 shared papers)
- Journals
- Frontiers in Pharmacology (4 papers)Stem Cell Research & Therapy (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Cell Death and Disease (2 papers)Cancer Letters (1 paper)
- Partner nations
- China
In The Last Decade
Xinyuan Ding
28 papers receiving 424 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 76
- Applied Microbiology and Biotechnology 9
- Molecular Biology 218
- Oncology 68
- Reproductive Medicine 21
Countries citing papers authored by Xinyuan Ding
This map shows the geographic impact of Xinyuan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyuan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyuan Ding more than expected).
Fields of papers citing papers by Xinyuan Ding
This network shows the impact of papers produced by Xinyuan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyuan Ding. The network helps show where Xinyuan Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinyuan Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 44 | |
| 2 | 2019 | 43 | |
| 3 | 2018 | 38 | |
| 4 | 2021 | 36 | |
| 5 | 2020 | 35 | |
| 6 | 2018 | 34 | |
| 7 | 2020 | 31 | |
| 8 | 2020 | 29 | |
| 9 | 2020 | 21 | |
| 10 | 2009 | 19 | |
| 11 | 2017 | 15 | |
| 12 | 2020 | 14 | |
| 13 | 2020 | 12 | |
| 14 | 2022 | 10 | |
| 15 | 2018 | 8 | |
| 16 | 2021 | 8 | |
| 17 | 2021 | 7 | |
| 18 | 2022 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2018 | 3 |
About Xinyuan Ding
Xinyuan Ding is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Epidemiology, having authored 31 papers that have together received 428 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Neurogenesis and neuroplasticity mechanisms (2 papers), Neuroblastoma Research and Treatments (2 papers), Protease and Inhibitor Mechanisms (2 papers), Immune cells in cancer (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Mesenchymal stem cell research (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Cancer Research (76 citations), Applied Microbiology and Biotechnology (9 citations), Molecular Biology (218 citations), Oncology (68 citations) and Reproductive Medicine (21 citations). Xinyuan Ding has collaborated with scholars based in China. Frequent co-authors include Wenjuan Wang, Min Jin, Yanyun Zhang, Zheng Wang, Mingxing Xue, Caihong Tan, Jiefang Huang, Kunwei Shen, Xiaosong Chen and Yuting Gu. Their work appears in journals such as Frontiers in Pharmacology, Stem Cell Research & Therapy, Journal of Experimental & Clinical Cancer Research, Cell Death and Disease and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.